跳至主要内容
临床试验/NCT05109377
NCT05109377Unknown不适用

Endocan Level in Patients With Erectile Dysfunction and Relationship With Tadalafil Treatment

Ankara Training and Research Hospital1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2021年6月24日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
发起方
入组人数
90
试验地点
1
主要终点
Rates of IIEF Score

研究概览

简要总结

The investigators analyze the patients' endocan levels, IIEF scores, and hormon levels both before and after tadalafil (5 or 20mg) treatment. The investigators want to see erectile dysfunction severity and tadalafil treatment relations with endocen level.

详细描述

The investigators will include at least 90 patients in study. Blood tests will taken before and after tadalafil treatment and will store at -80 celcius degree.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
Male
接受健康志愿者
是

入选标准

  • •Patients with erectile dysfuction

排除标准

  • •Psychogenic erectile dysfunction
  • •Erectile dysfunction associated with hormonal disorders
  • •Drug related erectile dysfunction

研究组 & 干预措施

5mg tadalafil

Other

5mg tadalafil

干预措施: Endocan (Diagnostic Test)

20mg tadalafil

Other

20 mg tadalafil

干预措施: Endocan (Diagnostic Test)

5mg tadalafil

Other

5mg tadalafil

干预措施: tadalafil (Drug)

20mg tadalafil

Other

20 mg tadalafil

干预措施: tadalafil (Drug)

结局指标

主要结局

Rates of IIEF Score

时间窗: 1 month

Levels of Endocan relationship with IIEF

次要结局

  • Levels of Endocan(1 month)

研究者

发起方
Ankara Training and Research Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Veysel Bayburtluoğlu

Principal Investigator

Ankara Training and Research Hospital

研究点 (1)

Loading locations...

相似试验